U.S. Healthcare Services Stock News

Short-seller report challenges the legitimacy of Babcock & Wilcox Enterprises' purported $2.4b contract and raises concerns about undisclosed related-party links. Securities fraud class action lawsuits have been filed, alleging failures in disclosure and questioning the integrity of the company’s contract reporting. These governance and disclosure issues are drawing attention to the risks around large power generation deals and potential impact on shareholder confidence. Babcock & Wilcox...

Acadia Pharmaceuticals (NasdaqGS:ACAD) announced the planned retirement of its Head of Research and Development, Dr. Elizabeth H.Z. Thompson. Dr. Thompson is expected to transition from her current role and remain with the company as a consultant through at least the end of 2026. Her consulting role is intended to support continuity around a key Phase 2 clinical readout in Alzheimer's disease psychosis and early Phase 3 planning. Acadia focuses on central nervous system conditions, where...

Wondering whether XPeng's current share price lines up with its underlying worth, or if the market is mispricing the story? This article breaks down what the numbers actually say. XPeng recently closed at US$15.83, with returns of a 5.0% decline over 7 days, a 10.6% decline over 30 days, a 22.5% decline year to date, a 19.9% decline over 1 year, a 52.2% gain over 3 years, and a 40.7% decline over 5 years, a mixed picture that raises questions about where value really sits today. These swings...

Brookfield Infrastructure Corporation reported first-quarter 2026 results showing sales of US$884 million versus US$929 million a year earlier, and a net loss of US$112 million compared with prior-year net income of US$389 million, while affirming a quarterly dividend of US$0.4550 per share payable on June 30, 2026. Beneath the weaker accounting earnings, management highlighted a 10% increase in funds from operations, progress toward about US$1 billion of capital recycling, and a 6% dividend...

If you are wondering whether Genius Sports at US$4.35 is a bargain or a value trap, the starting point is to understand what the current share price is really pricing in. The stock has seen a 2.7% decline over the last week, a 4.6% decline over the last month and a 59.6% decline year to date, while the 1 year return is a 60.6% loss and the 5 year return is a 76.8% loss, with only the 3 year period showing an 8.2% gain. These moves sit against a backdrop of ongoing attention on sports data,...

If you are wondering whether Universal Display at around US$96 per share still offers value, the key is to look past the headline share price and focus on what different valuation lenses are saying. The stock is down about 32.0% over the last year and 20.9% year to date, even though the past month shows a 7.4% gain after a softer 2.7% move over the last week. Recent coverage has focused on Universal Display’s position in the semiconductor space and how investors are weighing its long term...

If you are wondering whether Aramark’s current share price reflects its true value, the next sections walk through what the numbers actually say about the stock. Aramark shares last closed at US$44.95, with returns of 5.6% over 30 days, 22.9% year to date and 35.2% over 1 year, which has many investors reassessing both its potential and its risks. Over the past year Aramark has been in the spotlight as investors have tracked its performance and repositioned their expectations for the...

Moderna (MRNA) opened 2026 with Q1 results that continue the recent trend of revenue and losses sitting side by side, with trailing 12 month revenue at US$1.9 billion and a basic EPS loss of US$7.25 per share tied to a net loss of US$2.8 billion. Over recent quarters, the company has seen quarterly revenue move between US$108 million and US$1.9 billion with basic EPS ranging from a small profit of US$0.03 per share in Q3 2024 to losses of more than US$2.50 per share in several 2025 quarters,...

Vanguard Capital Management has disclosed a 7.3% stake in Cencora (NYSE:COR) via a Schedule 13G filing. The filing identifies Vanguard as one of Cencora’s largest institutional holders and classifies the position as being held for investment purposes. Cencora operates as a major player in pharmaceutical distribution and related healthcare services, sitting at the center of drug supply chains that connect manufacturers, pharmacies, and providers. With its scale and logistics capabilities,...

If you are wondering whether Snap at around US$6.29 is a bargain or a value trap, the key is understanding what the current price actually reflects about its future. The share price has moved sharply in the short term, with returns of 11.3% over the last 7 days and 35.9% over the last 30 days, set against a year to date return of negative 22.6% and a 1 year return of negative 25.6%. These moves come as Snap continues to sit in the spotlight of investors who are weighing its long term...

Piper Sandler Companies (PIPR) has entered Q1 2026 with trailing 12 month revenue of about US$1.9b and basic EPS of US$4.22. This is alongside year over year earnings growth of 55.3% and revenue growth of 9.8%. Over the past reported quarters, total revenue has moved from US$484.1 million in Q4 2024 to US$666.1 million in Q4 2025, while quarterly basic EPS has ranged from US$0.55 in Q3 2024 to US$1.69 in Q4 2025. Taken together, these figures present a picture of improving profitability and...

Tyler Technologies (NYSE:TYL) has completed its third largest acquisition, For The Record, adding court recording and transcription technology to its portfolio. The company has updated revenue guidance to reflect FTR and is leaning on the deal to support its shift toward cloud and AI-enabled solutions. Tyler is advancing its cloud migration plan, targeting nearly all new public safety clients and 80% of on premise customers to be in the cloud by 2030. For Tyler Technologies, a long time...

If you are wondering whether Dorman Products is attractively priced or looking stretched at around US$112.88, this article walks through the numbers that matter for valuation. The stock price sits at US$112.88, with returns of 1.5% over the last week, 11.9% over the last month, a 9.0% decline year to date, and a 2.1% decline over the last year. These returns are set against 27.7% and 8.1% over the past 3 and 5 years. Recent news coverage has focused on Dorman Products in the context of...

This article examines whether Paramount Skydance at around US$11.09 is a bargain or a value trap, and what the current price could be indicating about the stock. The share price has moved 1.1% over the last week and 19.9% over the last month, yet year to date it sits at a 15.9% decline and the 5 year return is a 68.3% decline, which can influence how investors think about both risk and potential reward. Investors have been watching Paramount Skydance closely after recent coverage of the...

Syndax Pharmaceuticals (SNDX) opened Q1 2026 with total revenue of US$64.9 million and a basic EPS loss of US$0.48, alongside a net loss of US$42.7 million. This puts fresh numbers around how the business is scaling its commercial model while still running in the red. Over recent quarters the company has reported revenue of US$7.7 million in Q4 2024, US$20.0 million in Q1 2025, and US$68.7 million in Q4 2025, with basic EPS losses of US$1.10, US$0.98, and US$0.78 over those same periods as it...

UMH Properties (UMH) opened 2026 with Q1 revenue of US$65.8 million and basic EPS of US$0.03, alongside trailing twelve month revenue of US$265.9 million and EPS of US$0.10 that sit against earnings growth forecasts of about 7.9% per year. Over recent periods, total revenue has moved from US$240.2 million in the trailing twelve months to Q4 2024 up to US$265.9 million in the latest trailing period, while quarterly basic EPS has ranged between a small loss of roughly US$0.01 in early 2025 and...

Wondering if H2O America at US$56.73 is offering fair value or if you might be paying up for the story? This article walks through the numbers so you can judge for yourself. The stock has slipped 5.0% over the last week and 2.9% over the last month, yet it still sits 15.2% higher year to date and 6.2% above its level a year ago. This follows a more challenging 3 year return of a 19.7% decline and a modest 0.7% gain over 5 years. Recent trading interest around H2O America has been supported...

Recent filings show Vanguard Portfolio Management and Vanguard Capital Management have quietly built passive stakes of around 5–7% in Edgewell Personal Care, even as the company faces weak organic revenue trends, declining productivity, and pressure on operating margins. At the same time, Edgewell’s elevated net-debt-to-EBITDA ratio has heightened concerns about overleverage and the possibility of shareholder dilution if business conditions deteriorate further. We’ll now examine how...

Enova International, Inc. reported past first-quarter 2026 results with revenue of US$528.96 million and net income of US$91.10 million, both higher than a year earlier, alongside increased basic and diluted earnings per share from continuing operations. The company also continued to return capital to shareholders through its recently completed share repurchase tranche while emphasizing record small-business originations and rising AI adoption among its customers. With strong first-quarter...

Wondering if Liberty Latin America at US$8.25 is offering value or just catching your eye because of recent headlines? This article walks through what the current share price might be implying about the business. The stock has dipped 1.6% over the last week and 1.9% over the last month, while still sitting on a 13.6% year to date return and a 54.8% return over the past year, with a near flat 0.2% three year return and a 43.0% decline over five years. These moves have come alongside ongoing...

Palisades Investment Partners has taken a new stake in SkyWater Technology (NasdaqCM:SKYT). The position is reportedly linked to expectations around SkyWater's planned acquisition by IonQ, targeted for completion later in 2026. The deal is expected to involve a mix of cash and stock, which may be relevant for existing and prospective shareholders. For you as an investor, the key point is that an institutional player is committing fresh capital to a company already in the middle of an...

If you are wondering whether Molina Healthcare's current share price reflects its true worth, this breakdown is designed to help you connect the stock's recent moves with what you might actually be paying for. The stock last closed at US$192.70, with returns of 9.5% over 7 days and 41.9% over 30 days, set against an 8.0% year to date result and a 39.4% decline over the past year. Recent headlines around Molina Healthcare have focused on the business as a managed care player in the US...

Starboard Value, a major shareholder in Lamb Weston Holdings (NYSE:LW), has publicly urged the company to reset its strategy. The activist investor is calling for an investor day, clearer earnings targets, and tighter cost control. Starboard argues that these steps are needed to rebuild management credibility and sharpen execution. Lamb Weston is a large frozen potato products supplier, with customers that range from global restaurant chains to retail grocery channels. The company sits at...

Cboe Global Markets (CBOE) just opened Q1 2026 earnings season with a solid set of headline figures, anchored by Q4 2025 revenue of US$1.2b and basic EPS of US$2.98, alongside trailing twelve month revenue of US$4.7b and EPS of US$10.46 that reflect its latest run rate. Over recent quarters the company has seen revenue move from US$1.11b in Q4 2024 to US$1.20b in Q4 2025, while quarterly EPS shifted from US$1.87 to US$2.98. This sets up a story where higher earnings and a 23.2% trailing net...